Literature DB >> 11158064

Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts.

R W Valyasevi1, S C Jyonouchi, C M Dutton, N Munsakul, R S Bahn.   

Abstract

Graves' ophthalmopathy (GO) is an orbital autoimmune disease that is closely associated with Graves' hyperthyroidism. Examination of retroorbital tissues in GO reveals an accumulation of glycosaminoglycans, increased fat volume, lymphocytic infiltration, and the presence of several inflammatory cytokines. A subpopulation of human orbital fibroblasts can be differentiated in vitro into cells with the morphologic features of adipocytes. We demonstrated recently that these differentiated cultures show increased expression of functional TSH receptor (TSHr). To determine whether the presence of inflammatory cytokines might impact adipogenesis or TSHr expression in these cultures, we treated orbital fibroblasts from normal individuals or GO patients with tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), or transforming growth factor-beta. We found that each of these cytokines inhibits TSH-dependent cAMP production and TSHr gene expression, and that TNF-alpha and IFN-gamma also inhibit morphological adipocyte differentiation. When cytokines were added after differentiation, the inhibition was less pronounced. Our results suggest that TNF-alpha, IFN-gamma, and transforming growth factor-beta may act within the orbit in GO to modulate expression of the putative orbital autoantigen, TSHr. In addition, the former two cytokines may play a role in determining the extent to which the volume of the orbital adipose tissue increases in this condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158064     DOI: 10.1210/jcem.86.2.7188

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

Review 2.  New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.

Authors:  R A Ajjan; A P Weetman
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

3.  Increased thyroidal fat and goitrous hypothyroidism induced by interferon-gamma.

Authors:  Hiroaki Kimura; Miho Kimura; William H Westra; Noel R Rose; Patrizio Caturegli
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

Review 4.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

5.  Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.

Authors:  G J Kahaly; H Bang; W Berg; M Dittmar
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

6.  Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Authors:  Chu Zhang; Xianfeng Zhang; Lizhen Ma; Fengying Peng; Jiao Huang; Hui Han
Journal:  Endocrine       Date:  2012-01-12       Impact factor: 3.633

Review 7.  Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.

Authors:  Sita Virakul; Leendert van Steensel; Virgil A S H Dalm; Dion Paridaens; P Martin van Hagen; Willem A Dik
Journal:  Eur Thyroid J       Date:  2014-12-06

Review 8.  TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 9.  TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect.

Authors:  Efstratios Kardalas; Spyridoula Maraka; Maria Papagianni; George Paltoglou; Charalampos Siristatidis; George Mastorakos
Journal:  Medicina (Kaunas)       Date:  2021-06-14       Impact factor: 2.430

10.  Differential expression analysis for pathways.

Authors:  Winston A Haynes; Roger Higdon; Larissa Stanberry; Dwayne Collins; Eugene Kolker
Journal:  PLoS Comput Biol       Date:  2013-03-14       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.